Department of Community Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai province, 50200 Thailand.
Faculty of Medicine, Chiang Mai University, Chiang Mai province, 50200 Thailand.
Vaccine. 2021 Dec 20;39(52):7554-7561. doi: 10.1016/j.vaccine.2021.11.031. Epub 2021 Nov 17.
COVID-19 pandemic is a worldwide problem. Vaccination as primary prevention is necessary. Thailand is in the initial phase of the vaccination program. However, the demand for this vaccine among Thais and expatriates living in Thailand is still unknown. This study aims to assess acceptance, attitude, and determinants for COVID-19 vaccination among Thai people and expatriates living in Thailand.
This was a cross-sectional study conducted in Thailand during May 2021. An online survey (REDcap) was distributed through online social media platforms. Adult (>18 years old) Thai and expatriates living in Thailand were invited. Any person who already received any COVID-19 vaccine was excluded from this study.
One thousand sixty-six responses were collected in this survey. A total of 959 were available for analysis. Six hundred thirty-seven 637 responses were from Thais and 322 responses from expatriates living in Thailand. The acceptance rate was significantly higher among expatriates than local people (57.8% vs 41.8%, p-value < 0.001). The acceptance rate increased up to 89.0-91.3% if they could select the vaccine brand, and 80.7-83.2% when they were recommended by the health care professionals. Both groups had a similar mean attitude score toward COVID-19 vaccination. Being Thai, health care worker, good compliance to social distancing, accepting serious side effects at level 1 per 100,000, and having a good attitude toward COVID-19 vaccination were associated with vaccine acceptance.
Thailand's COVID-19 vaccination program could improve the acceptance rate by informing the public about vaccine efficacy, vaccine benefit, and vaccine safety. Moreover, supplying free of charge high efficacy alternative vaccines and letting all people living in Thailand make their own vaccine choices could increase the acceptance rate.
COVID-19 大流行是一个全球性问题。接种疫苗作为主要预防措施是必要的。泰国正处于疫苗接种计划的初始阶段。然而,泰国人和在泰国生活的外国人对这种疫苗的需求尚不清楚。本研究旨在评估泰国人和在泰国生活的外国人对 COVID-19 疫苗的接受程度、态度和决定因素。
这是一项于 2021 年 5 月在泰国进行的横断面研究。通过在线社交媒体平台分发在线调查(REDCap)。邀请成年(>18 岁)泰国人和在泰国生活的外国人参与。任何已接种任何 COVID-19 疫苗的人都被排除在本研究之外。
本研究共收集了 1066 份回复。共有 959 份回复可用于分析。637 份回复来自泰国人,322 份回复来自在泰国生活的外国人。外国人的接种接受率明显高于当地人(57.8%比 41.8%,p 值<0.001)。如果他们可以选择疫苗品牌,接种接受率可增加到 89.0-91.3%,如果由医疗保健专业人员推荐,接种接受率可增加到 80.7-83.2%。两组对 COVID-19 疫苗接种的平均态度评分相似。泰国人、医疗保健工作者、良好遵守社交距离、接受每 10 万人 1 级严重副作用和对 COVID-19 疫苗接种的良好态度与疫苗接种接受度相关。
泰国的 COVID-19 疫苗接种计划可以通过向公众宣传疫苗的有效性、疫苗的益处和疫苗的安全性来提高接种接受率。此外,免费提供高效替代疫苗,并让所有在泰国生活的人自行选择疫苗,可以提高接种接受率。